Health & Life Co., Ltd. (TPEX:1781)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.25
-0.10 (-0.88%)
Jul 29, 2026, 1:24 PM CST

Health & Life Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-76.18-61.6724.24-33.23-17.55-62.34
Depreciation & Amortization
14.2814.6723.4824.4424.1817.17
Loss (Gain) From Sale of Assets
---0.06-0.01-1.45-
Loss (Gain) From Sale of Investments
0.10.320.02---
Provision & Write-off of Bad Debts
--0.010.011.06-0.69-0
Other Operating Activities
-5.56-3.92-4.49-4.75-16.27-26.09
Change in Accounts Receivable
64.4346.25-35.1335.68-37.84-14.29
Change in Inventory
-6.9711.4679.329.180.42-41.57
Change in Accounts Payable
21.63-10-48.1424.54-8.83-53.83
Change in Unearned Revenue
-2.715.822.83-11.92-1.5111.11
Change in Other Net Operating Assets
-3.270.26-8.6619.92-21.1538.69
Operating Cash Flow
5.743.1833.3984.91-80.7-131.15
Operating Cash Flow Growth
-66.84%-90.46%-60.67%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.43-6.92-2.74-7.97-4.74-12.38
Sale of Property, Plant & Equipment
--0.50.112.13-
Sale (Purchase) of Intangibles
-1.27-1.27-0.11-0.13-7.58-1.53
Investment in Securities
5050.14-89.27-1.05--
Other Investing Activities
-0.440.022.180.25-0.13-2.12
Investing Cash Flow
39.8741.96-89.44-8.78-10.32-16.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--195.01264312.65878.28
Long-Term Debt Issued
--217.89---
Total Debt Issued
--412.9264312.65878.28
Short-Term Debt Repaid
---260.01-314.6-261.08-947.08
Long-Term Debt Repaid
--21.77-23.97-24.06-25.67-22.27
Total Debt Repaid
-18.67-21.77-283.98-338.66-286.75-969.35
Net Debt Issued (Repaid)
-18.67-21.77128.93-74.6625.9-91.07
Other Financing Activities
-0.14-0.14-0.24-0.010.01-0.03
Financing Cash Flow
-18.81-21.91128.68-74.6725.91-91.1

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.88-2.613.67-7.3821.735.03
Net Cash Flow
27.6820.6376.3-5.92-43.37-233.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2.69-3.7430.6576.94-85.44-143.53
Free Cash Flow Growth
---60.16%---
Free Cash Flow Margin
-0.72%-0.94%4.34%12.80%-10.71%-17.68%
Free Cash Flow Per Share
-0.06-0.080.611.62-1.80-3.03
Levered Free Cash Flow
22.0518.29.4982.6-85.23-117.57
Unlevered Free Cash Flow
25.7221.9311.685.89-83.27-115.64

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.30.452.025.273.142.87
Cash Income Tax Paid
0.391.290.390.280.41-
Change in Working Capital
73.153.78-9.897.39-68.91-59.89